Compare RMT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMT | PACB |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.2M | 459.0M |
| IPO Year | N/A | 2010 |
| Metric | RMT | PACB |
|---|---|---|
| Price | $11.43 | $1.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.10 |
| AVG Volume (30 Days) | 143.0K | ★ 5.5M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 7.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.22 |
| Revenue Next Year | N/A | $12.41 |
| P/E Ratio | $7.58 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $7.25 | $0.85 |
| 52 Week High | $12.50 | $2.73 |
| Indicator | RMT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 35.78 |
| Support Level | $11.36 | $1.18 |
| Resistance Level | $11.88 | $1.37 |
| Average True Range (ATR) | 0.26 | 0.09 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 17.33 | 19.09 |
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.